SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.

Advertisement


Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

How Listing Ukraine As A Priority Foreign Country In Special 301 Violates WTO Agreements

Prof. Sean Flynn asks whether US sanctions of Ukraine under the US Special 301 program violates World Trade Organization rules. He also asks whether the operation of watch lists threatening sanctions for intellectual property matters could be challenged under the WTO even prior to any sanction going into effect.





Latest Comments
  • As it happens, I own and create "intellectual prop... »
  • So long term planning of the UN Development Decade... »

  • For IPW Subscribers
    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    WIPO To Launch New Drug R&D Database For Neglected Disease Licences

    Published on 19 October 2011 @ 3:26 pm

    By , Intellectual Property Watch

    The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva.

    The project will target least-developed countries and is likely to include a database and a space for creating partnerships . But budget, oversight and the role of member states is still unclear.

    Launch of the project, called Re:Search, is scheduled for 26 October at WIPO. Some details of the project are available here, and a WIPO spokesperson said more details would become available on the day of the launch, which will be attended by WIPO Director General Francis Gurry and WHO Director General Margaret Chan.

    According to the website, the aim is to boost discovery and development of medicines, vaccines and diagnostics for neglected tropical diseases plus malaria and tuberculosis through greater availability of intellectual property to researchers. Neglected diseases would include Chagas disease, dengue fever, human African trypanosomiasis, leishmaniasis, and many others.

    According to sources, the consortium will be managed by WIPO, along with a governance board of participants. The consortium is said to be cosponsored by BIO Ventures for Global Health (BVGH), a Seattle-based group with Gates Foundation funding, and a biotechnology industry orientation. Other possible participants could be the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), with its president, AstraZeneca CEO David Brennan, possibly attending the launch, the government of Tanzania, the United States government, the Drugs for Neglected Diseases initiative, and Medicines for Malaria Venture, sources said. The Brazilian public-private drug research group Fiocruz was also in consideration.

    The project’s principle in accelerating industry R&D for developing countries is to find common ground between the goals of the global health community and the pragmatic needs of companies, a source said.

    The consortium is expected to involve a database hosted by WIPO with information about intellectual property that can be licensed and other materials. It also is expected to have a “partnership hub” managed by BVGH for participants to learn more and network, and it will likely involve other supporting activities such as helping with negotiations of licensing agreements.

    It appears that WIPO will pay for a Re:Search secretariat housed at WIPO to provide services along with the partnership hub administrator. There would be a governance committee made up of consortium members, offering guidance.

    The relationship of the WIPO-WHO initiative to other initiatives such as the Medicines Patent Pool, which targets HIV/AIDS, is not clear. But if WIPO’s choice of focus is strictly least-developed countries, it could lower the bar on the Medicines Patent Pool’s concerted efforts in recent months to persuade pharmaceutical companies to share their patents for low-cost treatments in larger developing countries as well as least-developed countries. Companies have been willing to discuss allowing affordable versions of their patented medicines in LDCs because they have little market there anyway. But they have been tougher about mid-sized developing economies.

    The current UN definition of LDCs includes 33 countries in Africa, 15 in Asia (including several small island nations), and one in Latin America (Haiti).

    WIPO Joins Research4Life Initiative

    Separately, WIPO announced this week that it had thrown its hat into the ring of organisations contributing to providing affordable access to critical scientific research for poor populations. WIPO added its Access to Research for Development and Innovation (ARDI) program, in which it partners with the publishing industry to increase developing country capacity to access scientific and technical information.

    William New may be reached at wnew@ip-watch.ch.

     

    Comments

    1. New WIPO-WHO Drug R&D Database Would Pool Neglected Disease Licences – Intellectual Property Watch (blog) | Property Developer and Investment News says:

      [...] here: New WIPO-WHO Drug R&D Database Would Pool Neglected Disease Licences – Intellectual Prope… Posts Related to New WIPO-WHO Drug R&D Database Would Pool Neglected Disease Licences – [...]

    2. Reji K. Joseph says:

      Even when the technology for NTDs is in place who will manufacture and distribute them? In India, the public sector Central Drug Research Institute licensed a number of technologies for diseases like Malaria to leading Indian firms; but they were simply not interested in further developing it. Equally important is the devising of a mechanism that would encourage the firms to manufacture and distribute NTD drugs.

    3. WIPO Re:Search Webpage Goes Live, Shows Sponsors | Intellectual Property Watch says:

      [...] In The PhilippinesIPOPHL denies anti-piracy summit is fostering corp… »Reji K. Joseph on New WIPO-WHO Drug R&D Database For Neglected Disease LicencesEven when the technology for NTDs is in place who … »Older » For IPW Subscribers A [...]


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

     

     
    Your IP address is 107.20.129.212